Walleye Capital’s MacroGenics MGNX Stock Holding History

Walleye Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.89M	Buy	408,150 +72,885	+22%	+$276K	0.01%	1565
2026 Q1	$969K	Buy	335,265 +302,085	+910%	+$644K	﹤0.01%	2105
2025 Q4	$53.4K	Buy	33,180 +8,000	+32%	+$12.6K	﹤0.01%	4061
2025 Q3	$42.3K	Hold	25,180	–	–	﹤0.01%	4064
2025 Q2	$30.5K	Buy	+25,180	New	+$36.5K	﹤0.01%	4167
2025 Q1	–	Sell	-38,353	Closed	-$125K	–	4769
2024 Q4	$125K	Sell	38,353 -76,391	-67%	-$275K	﹤0.01%	4030
2024 Q3	$378K	Sell	114,744 -89,201	-44%	-$348K	﹤0.01%	3552
2024 Q2	$867K	Buy	203,945 +156,630	+331%	+$1.53M	﹤0.01%	2995
2024 Q1	$696K	Buy	+47,315	New	+$715K	﹤0.01%	2913
2023 Q1	–	Sell	-83,301	Closed	-$559K	–	4203
2022 Q4	$559K	Sell	83,301 -57,737	-41%	-$317K	0.01%	1375
2022 Q3	$488K	Sell	141,038 -437,150	-76%	-$1.67M	0.01%	1488
2022 Q2	$1.71M	Buy	578,188 +364,210	+170%	+$1.91M	0.05%	415
2022 Q1	$1.89M	Buy	+213,978	New	+$2.36M	0.05%	396

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Walleye Capital's MGNX Position: Q2 2026 in Review

Walleye Capital increased its MacroGenics (MGNX) stake by 22% in Q2 2026, buying an estimated $276K and bringing the position to 408,150 shares worth $1.89M. The position accounts for 0.01% of the portfolio, ranked #1565.

Walleye Capital first reported a position in MGNX in Q1 2022 and has held it in 13 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Walleye Capital held 408,150 shares of MacroGenics worth $1.89M as of Q2 2026.
Walleye Capital bought 72,885 MacroGenics shares in Q2 2026, an estimated $276K.
MacroGenics made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1565 holding.
Walleye Capital first reported a position in MacroGenics in Q1 2022 and has held it in 13 quarters since.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.